Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules

Biomaterials

Volumn 22, Issue 22, 2001, Pages 2967-2979

  Mosqueira, Vanessa Carla Furtado ^a,d   Legrand, Philippe ^a   Gulik, Annette ^b   Bourdon, Olivier ^c   Gref, Ruxandra ^a   Labarre, Denis ^a   Barratt, Gillian ^a  

^a UNIV PARIS SUD   (France)

^b CENTRE DE GÉNÉTIQUE MOLÉCULAIRE   (France)

^c CNRS   (France)

^d FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

Author keywords

Cellular uptake; Complement activation; Nanocapsules; Physicochemical characterization; Poly(D,L lactide co ethylene oxide) copolymers; Surface properties

Indexed keywords

ADSORPTION; ELECTROPHORESIS; GRAFTING (CHEMICAL); MORPHOLOGY; NANOSTRUCTURED MATERIALS; PROTEINS;

MACROPHAGES;

PHYSICAL CHEMISTRY;

MACROGOL; NANOCAPSULE; PHOSPHOLIPID; POLYLACTIDE; POLYMER;

ADSORPTION; ARTICLE; CELL TRANSPORT; CHEMICAL MODIFICATION; CHROMATOGRAPHY; COMPLEMENT ACTIVATION; CONFOCAL MICROSCOPY; HYDROPHILICITY; IMMUNOELECTROPHORESIS; MACROPHAGE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN BINDING; SCANNING ELECTRON MICROSCOPY; SURFACE CHARGE; SURFACE PROPERTY; ZETA POTENTIAL;

ADSORPTION; ANIMALS; BIOCOMPATIBLE MATERIALS; CAPSULES; CELL LINE; CHEMISTRY, PHYSICAL; COMPLEMENT ACTIVATION; COMPLEMENT C3; FREEZE FRACTURING; HUMANS; MACROPHAGES; MATERIALS TESTING; MICE; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; NANOTECHNOLOGY; POLYESTERS; POLYETHYLENE GLYCOLS; PROTEIN BINDING; SURFACE PROPERTIES;

EID: 0035889833     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(01)00043-6     Document Type: Article

References (32)

1. Long circulating microparticulate drug carriers
2. Kinetics of blood component adsorption on poly(D,L-lactic acid) nanoparticles; evidence of complement C3 component involvement
3. Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics
4. Stealth corona-core nanoparticles surface modified by polyethylene glycol (PEG); influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption
5. Activation of complement system at the interface between blood and artificial surfaces
6. Adsorption of ethoxylated surfactants on nanoparticles. I. Characterization by hydrophobic interaction chromatography
7. Effect of PEO density on long-circulating PLA-PEO nanoparticles which are very low complement activators
8. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres
9. Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles
10. Sterically stabilized liposomes
11. Biodegradable long-circulating polymeric nanospheres
12. Non-stealth (poly(lactic/albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriers
13. Interactions between a macrophage cell line (J774A1) and surface-modified poly(D,L-lactide) nanocapsules bearing poly(ethylene glycol)
14. In vitro release kinetic studies of PEG-modified nanocapsules and nanospheres loaded with a lipophilic drug; halofantrine base
15. Nanocapsule formation by interfacial polymer deposition following solvent displacement
16. Quantitative estimation of proteins by electrophoresis in agarose gels containing antibodies
17. Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system
18. Superoxide anion and hydrogen peroxide production by chemically elicited peritoneal macrophages-induction by multiple nonphagocytic stimuli
19. Stability of lipid emulsions for drug delivery
20. Poly(D,L-lactide) nanocapsules prepared by a solvent displacement process; influence of the composition on physicochemical and structural properties
21. In vitro characterization of poly(methyl-methacrylate) nanoparticles and correlation to their in-vivo fate
22. Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers
23. Interfacial thickness of liposomes containing poly(ethylene glycol)-cholesterol from electrophoresis
24. Stealth Me. PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system
25. Biodegradable nanoparticles-from sustained release formulations to improve site specific drug delivery
26. Interactions of liposomes and lipid-based carrier systems with blood proteins; relation to clearance behavior in-vivo
27. The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes
28. Interfacial and emulsion stabilizing properties of amphiphilic water-soluble poly(ethylene glycol)-poly(lactic acid) copolymers for the fabrication of biocompatible nanoparticles
29. The stability of polymer latices
30. Effects of Pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells
31. Endocytosis and the recycling of plasma membrane
32. Pinocytosis and phagocytosis; the effect of size of a particulate substrate on its mode of capture by rat peritoneal macrophages cultured in vitro